Avantor stock hits 52-week low at $15.36 amid market challenges

Published 04/04/2025, 15:10
Avantor stock hits 52-week low at $15.36 amid market challenges

Avantor Inc . (NYSE: NYSE:AVTR) stock has tumbled to a 52-week low, reaching a price level of $15.36 USD, reflecting a significant downturn in the company’s market valuation to $10.38 billion. InvestingPro analysis suggests the stock is currently undervalued, trading at a modest P/E ratio of 14.8x. This latest price point underscores a challenging period for the global provider of mission-critical products and services for the biopharma, healthcare, education, and advanced technologies & applied materials industries. Over the past year, Avantor’s stock has experienced a steep decline, with a 1-year change showing a substantial drop of -41.05%. Investors are closely monitoring the company’s performance and potential market catalysts that may influence its recovery or further descent.

In other recent news, Avantor Inc. reported its fourth-quarter 2024 results, which showed an earnings per share (EPS) of $0.27, slightly surpassing the analyst estimate of $0.26, but the company missed revenue expectations with $1.69 billion compared to the anticipated $1.71 billion. The full-year 2024 net sales were $6.78 billion, marking a 3% decrease from the previous year. In response to these earnings, several firms adjusted their price targets for Avantor. RBC Capital Markets lowered its price target to $31, maintaining an Outperform rating, noting strong internal operations but a cautious market. Bernstein reduced its price target to $22, maintaining a Market Perform rating, citing concerns about the underperformance in the Laboratory Solutions segment. Stifel adjusted its price target to $26, holding a Buy rating, and highlighted Avantor’s attractive valuation and strategic market position despite the challenges. Analysts also noted Avantor’s strong operational expense control and impressive free cash flow conversion of 110%, which the company is using to reduce debt. As Avantor navigates these developments, its focus on cost reduction and margin improvement remains a key area of interest for investors.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.